• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchScribe Therapeutics
    Picture of Scribe Therapeutics logo

    SCTX — Scribe Therapeutics Share News

    $17.440.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    • Market Cap
      $330.17m
    • Enterprise Value
      $445.31m
    • Revenue
      $51.17m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SCTX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SCTX Dividends
    • Brief: Scribe Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights

      02/09/2026 21:31
    • Scribe Therapeutics surges in New York debut after upsized $128.7 million IPO

      24/07/2026 19:27
    • U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty

      24/07/2026 19:22
    • U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor

      24/07/2026 16:50
    • NASDAQ RESUMED AT 11:50 AM

      24/07/2026 16:50
    • U.S. STOCKS ON THE MOVE-Tenet Healthcare, Intel, Verizon

      24/07/2026 15:11
    • Scribe Therapeutics set for New York debut after upsized $128.7 million IPO

      24/07/2026 13:08
    • NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM

      24/07/2026 09:00
    • Brief: Scribe Therapeutics Announces Pricing Of Upsized Initial Public Offering

      24/07/2026 02:10
    • Brief: Scribe Therapeutics - IPO Price Expected Between $13 And $15 Per Share - SEC Filing

      20/07/2026 12:27

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.